Genadyne Biotechnologies | DMR-06-091- Rev F
Precautions
Precautions should be taken for patients who are or may be: receiving anticoagulant therapy, suffering
from difficult hemostasis, untreated for malnutrition and non-compliant or combative.
Standard Precautions
To reduce the risk of transmission of blood borne pathogens, apply standard precautions for infection
control with all patients, per institutional protocol, regardless of their diagnosis or presumed infection
status. In addition to gloves, use gown and goggles if exposure to body fluid is likely.
Continuous versus Variable Therapy
Continuous, rather than Variable, Genadyne XLR8+ Therapy is recommended over unstable
structures, such as an unstable chest wall or non-intact fascia, in order to help minimize movement and
stabilize the wound bed. Continuous Therapy is also generally recommended for patients at increased
risk of bleeding, highly exudating wounds, fresh flaps and grafts and wounds with acute enteric fistulae.
Patient Size and Weight
The size and weight of the patient should be considered when prescribing Genadyne XLR8+ Therapy.
Infants, children, certain small adults and elderly patients should be closely monitored for fluid loss and
dehydration. Also, patients with highly exudating wounds or large wounds in relation to the patient size
and weight should be closely monitored, as they may have a risk of excessive fluid loss and
dehydration. When monitoring fluid output, consider the volume of fluid in both the tubing and canister.
Spinal Cord Injury
In the event a patient experiences autonomic hyperreflexia (sudden elevation in blood pressure or heart
rate in response to stimulation of the sympathetic nervous system), discontinue Genadyne XLR8+
Therapy to help minimize sensory stimulation and seek immediate medical assistance.
Bradycardia
To minimize the risk of bradycardia, the Genadyne XLR8+ Therapy dressing must not be placed in
proximity to the vagus nerve.
Enteric Fistulas
Wounds with enteric fistulas require special precautions to optimize Genadyne XLR8+ Therapy. In
certain circumstances, the Genadyne XLR8+ Therapy may help to promote healing in wounds with an
enteric fistula. When the physician orders the Genadyne XLR8+ Therapy, it is recommended that
support from an expert clinician is sought. Genadyne XLR8+ Therapy is not recommended or designed
for fistula effluent management or containment, but as an aid to wound healing. Genadyne XLR8+
Therapy is not recommended if enteric fistula effluent management or containment is the sole goal of
this therapy.
To Next Page
Loading...
